Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients

Mahmut Civilibal1, Salim Caliskan, Huseyin Oflaz

  • 1Department of Pediatric Nephrology, Istanbul University Cerrahpasa Medical Faculty, 34303 Cerrahpasa, Istanbul, Turkey. drcivilibal@hotmail.com

Insights

Cardiovascular disease (CVD) in pediatric end-stage renal disease (ESRD) patients is linked to higher carotid intima-media thickness (cIMT) and left ventricular mass index (LVMI). Hypertension and anemia are key risk factors, suggesting improved management is crucial.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Medicine
  • Renal Disease Research

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in pediatric end-stage renal disease (ESRD) patients.
  • Understanding cardiovascular risk markers and their predictors is crucial for this vulnerable population.

Purpose of the Study:

  • To analyze carotid intima-media thickness (cIMT), endothelium-dependent dilatation (EDD), and left ventricular mass index (LVMI) as cardiovascular risk markers in pediatric dialysis patients.
  • To identify independent risk factors for these markers in children and adolescents with ESRD.

Main Methods:

  • Study included 39 pediatric dialysis patients (15 hemodialysis, 24 peritoneal dialysis) and 15 healthy controls.
  • cIMT and EDD assessed via high-resolution ultrasound; LVMI calculated from echocardiography.
  • Statistical analysis included univariate and stepwise linear regression.

Main Results:

  • Pediatric dialysis patients showed significantly higher cIMT standard deviation scores (SDS), LVMI, total homocysteine (tHcy), and high-sensitivity C-reactive protein (hs-CRP) compared to controls.
  • EDD did not differ between groups.
  • Hemodialysis patients had higher mean hs-CRP than peritoneal dialysis patients.
  • Indexed systolic blood pressure (SBP) and hemoglobin were independent predictors of LVMI; indexed diastolic blood pressure (DBP) predicted cIMT.

Conclusions:

  • Atherosclerosis and left ventricular hypertrophy in pediatric ESRD patients are multifactorial.
  • Effective management of hypertension and anemia is essential for preventing and improving CVD in these children.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...